Cargando…

Immune ambivalence: The schizophrenic bleomycin

In addition to cytotoxic effects, anticancer agents can exert multiple immunomodulatory functions. We have recently described the molecular mechanisms whereby bleomycin can 1) promote endoplasmic reticulum stress, causing the immunogenic death of cancer cells and hence strengthening antitumor CD8(+)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mignot, Grégoire, Bugaut, Hélène, Ghiringhelli, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850019/
https://www.ncbi.nlm.nih.gov/pubmed/24327935
http://dx.doi.org/10.4161/onci.25737
_version_ 1782294028071469056
author Mignot, Grégoire
Bugaut, Hélène
Ghiringhelli, François
author_facet Mignot, Grégoire
Bugaut, Hélène
Ghiringhelli, François
author_sort Mignot, Grégoire
collection PubMed
description In addition to cytotoxic effects, anticancer agents can exert multiple immunomodulatory functions. We have recently described the molecular mechanisms whereby bleomycin can 1) promote endoplasmic reticulum stress, causing the immunogenic death of cancer cells and hence strengthening antitumor CD8(+) T cell responses; and 2) induce the secretion of transforming growth factor β (TGFβ), which stimulates regulatory T cells. This suggests that bleomycin may be favorably combined with TGFβ-targeting strategies.
format Online
Article
Text
id pubmed-3850019
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-38500192013-12-10 Immune ambivalence: The schizophrenic bleomycin Mignot, Grégoire Bugaut, Hélène Ghiringhelli, François Oncoimmunology Author's View In addition to cytotoxic effects, anticancer agents can exert multiple immunomodulatory functions. We have recently described the molecular mechanisms whereby bleomycin can 1) promote endoplasmic reticulum stress, causing the immunogenic death of cancer cells and hence strengthening antitumor CD8(+) T cell responses; and 2) induce the secretion of transforming growth factor β (TGFβ), which stimulates regulatory T cells. This suggests that bleomycin may be favorably combined with TGFβ-targeting strategies. Landes Bioscience 2013-09-01 2013-07-23 /pmc/articles/PMC3850019/ /pubmed/24327935 http://dx.doi.org/10.4161/onci.25737 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Mignot, Grégoire
Bugaut, Hélène
Ghiringhelli, François
Immune ambivalence: The schizophrenic bleomycin
title Immune ambivalence: The schizophrenic bleomycin
title_full Immune ambivalence: The schizophrenic bleomycin
title_fullStr Immune ambivalence: The schizophrenic bleomycin
title_full_unstemmed Immune ambivalence: The schizophrenic bleomycin
title_short Immune ambivalence: The schizophrenic bleomycin
title_sort immune ambivalence: the schizophrenic bleomycin
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850019/
https://www.ncbi.nlm.nih.gov/pubmed/24327935
http://dx.doi.org/10.4161/onci.25737
work_keys_str_mv AT mignotgregoire immuneambivalencetheschizophrenicbleomycin
AT bugauthelene immuneambivalencetheschizophrenicbleomycin
AT ghiringhellifrancois immuneambivalencetheschizophrenicbleomycin